Literature DB >> 21999200

Human amniotic glycodelin actively regulates changes in β-catenin immunoreactivity in cultured human umbilical vein endothelial cells (HUVEC).

Alessandro Pala1, Piera D'Elia, Giuseppe Spampinato, Eugenia Pittaluga, Giuseppe Benagiano.   

Abstract

OBJECTIVE: Assessment of the capacity of Glycodelin A (GdA) to modulate the aggregation of cultured human umbilical vein endothelial cells.
METHODS: Highly purified Glycodelin A (GdA) from late first trimester amniotic fluid has been added to cultured cells and its biological activity has been observed with immunofluorescent staining of β-catenin molecules.
RESULTS: GdA induces translocation of β-catenin molecules promoting cell-to-cell adhesion and formation of adherents junctions through cytoskeletal reorganization.
CONCLUSION: These data provide further mechanistic insight into the specificity of cell-to-cell adhesion, thus corroborating the role of GdA in promoting angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999200     DOI: 10.3109/14767058.2011.629258

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  [Synovialitis of the arthrofibrotic type: criteria of a new synovialitis type for the diagnosis of arthrofibrosis].

Authors:  V Krenn; M Ruppert; P Knöß; D Kendoff; C Poremba; M Thomsen; M Skutek; J Hassenpflug; R Ascherl; M G Krukemeyer; G Matziolis; P Thomas; T Gehrke
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

2.  Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: its role during implantation window.

Authors:  Francisco J Valdez-Morales; Armando Gamboa-Domínguez; Victor S Vital-Reyes; Juan C Hinojosa Cruz; Jesús Chimal-Monroy; Yanira Franco-Murillo; Marco Cerbón
Journal:  Reprod Health       Date:  2015-05-17       Impact factor: 3.223

Review 3.  The Roles of Glycodelin in Cancer Development and Progression.

Authors:  Juan Cui; Yanguo Liu; Xiuwen Wang
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.